AST Clinical Investigation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01268345

Enrollment

Registered

2010-12-30

Start date

2010-10-31

Completion date

2010-12-31

Last updated

2010-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

blood glucose

Brief summary

Blood glucose monitoring system are tested in the alternative site to validate the accuracy of the blood glucose.

Interventions

DEVICEblood glucose monitor

Blood glucose monitor is used to monitor the blood glucose level of the human-being

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 78 Years

Healthy volunteers

Yes

Inclusion criteria

* people ( disbetes people)with at least 8 hours of limosis

Exclusion criteria

* After meal(when doing the test) * take Hypoglycemic Drugs(when doing the test) * with insulin(when doing the test) * after strenuous exercise(when doing the test) * Pregnant women * neonates * patients in a hyperglycemic-hyperosmolur state, with or without ketosis. * patients who are dehydrated, hypertensive, hypotensive or in shock.

Design outcomes

Primary

Measure	Time frame
blood glucose value	5 seconds

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026